Hangzhou Tigermed Consulting Co Ltd
SZSE:300347

Watchlist Manager
Hangzhou Tigermed Consulting Co Ltd Logo
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Watchlist
Price: 64.82 CNY -4.11% Market Closed
Market Cap: 48.1B CNY
Have any thoughts about
Hangzhou Tigermed Consulting Co Ltd?
Write Note

Hangzhou Tigermed Consulting Co Ltd
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Hangzhou Tigermed Consulting Co Ltd
Total Receivables Peer Comparison

Comparables:
603259
300759
2269
1548
W
2268

Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Total Receivables
ÂĄ4.3B
CAGR 3-Years
35%
CAGR 5-Years
32%
CAGR 10-Years
35%
WuXi AppTec Co Ltd
SSE:603259
Total Receivables
ÂĄ10.1B
CAGR 3-Years
23%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Total Receivables
ÂĄ2.9B
CAGR 3-Years
23%
CAGR 5-Years
25%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Total Receivables
ÂĄ6.8B
CAGR 3-Years
13%
CAGR 5-Years
41%
CAGR 10-Years
N/A
Genscript Biotech Corp
HKEX:1548
Total Receivables
$299.5m
CAGR 3-Years
47%
CAGR 5-Years
43%
CAGR 10-Years
N/A
W
WuXi XDC Cayman Inc
HKEX:2268
Total Receivables
ÂĄ985.8m
CAGR 3-Years
177%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Hangzhou Tigermed Consulting Co Ltd's Total Receivables?
Total Receivables
4.3B CNY

Based on the financial report for Jun 30, 2024, Hangzhou Tigermed Consulting Co Ltd's Total Receivables amounts to 4.3B CNY.

What is Hangzhou Tigermed Consulting Co Ltd's Total Receivables growth rate?
Total Receivables CAGR 10Y
35%

Over the last year, the Total Receivables growth was 16%. The average annual Total Receivables growth rates for Hangzhou Tigermed Consulting Co Ltd have been 35% over the past three years , 32% over the past five years , and 35% over the past ten years .

Back to Top